Devlin Jodi
SEC CIK 1992151 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | Pres, COMMERC. Ops | 97.4K | — | $37.8K | 7 | 2024-02-12 | 2026-03-11 |
Most active insiders at TLSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stansky Michael P | Dir | $3.01M | — |
| 2 | Szela Mary T | CEO, Pres, Dir | $227.8K | $79.4K |
| 3 | Wahlstrom Mats | Dir | $151.8K | — |
| 4 | Valle William | Dir | $125.0K | — |
| 5 | Gordon Gary B. | Dir | $64.6K | — |
| 6 | Patience David | CFO | $32.2K | — |
| 7 | Marshak Richard | Chief Commercial Off | — | $15.7K |
| 8 | Stevens Jennifer | Chief Regulatory Off | — | $14.5K |
| 9 | Devlin Jodi | Chief of Clinical Ops | — | $13.2K |
| 10 | Cox Bryan F. | Chief of Research | — | $13.1K |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-20 | 2026-03-11+ | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Ops | S - Sale | $4.11 | -3,207 | 97.4K | -3% | -$13.2K |
| D | 2025-11-25 | 2025-11-24 | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Ops | A - Grant | $0.00 | +50.0K | 100.6K | +99% | $0 |
| 2025-05-21 | 2025-05-19 | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Ops | A - Grant | $5.18 | +24.1K | 57.5K | +72% | +$125.0K | |
| 2025-05-21 | 2025-05-19 | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Ops | S - Sale | $5.18 | -4,764 | 52.8K | -8% | -$24.7K | |
| 2025-02-19 | 2025-02-18 | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of Clinical Ops | A - Grant | $0.00 | +5,272 | 33.4K | +19% | $0 | |
| D | 2025-01-29 | 2025-01-27 | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Chief of COMMERC. Ops | A - Grant | $0.00 | +10.6K | 28.1K | +61% | $0 |
| D | 2024-02-14 | 2024-02-12 | TLSI | TriSalus Life Sciences, Inc. | Devlin Jodi | Pres, COMMERC. Ops | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations